A bioinformatics approach identifies signal transducer and activator of transcription-3 and checkpoint kinase 1 as upstream regulators of kidney injury molecule-1 after kidney injury

Journal of the American Society of Nephrology

Volumn 25, Issue 1, 2014, Pages 105-118

  Ajay, Amrendra Kumar ^a,b   Kim, Tae Min ^a,b   Ramirez Gonzalez, Victoria ^c   Park, Peter J ^a,b   Frank, David A ^b,d   Vaidya, Vishal S ^a,b,e  

^a HARVARD INSTITUTES OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHECKPOINT KINASE 1; KIDNEY INJURY MOLECULE 1; KRUPPEL LIKE FACTOR 4; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; STAT3 PROTEIN;

ANIMAL CELL; ARTICLE; BIOINFORMATICS; CANCER CELL CULTURE; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; KIDNEY CORTEX; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE DAMAGE; KIDNEY TUBULE EPITHELIUM; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT;

EID: 84891802904     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013020161     Document Type: Article

References (50)

1. Ichimura T, Bonventre JV, Bailly V, Wei H, Hession CA, Cate RL, SanicolaM: Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem273: 4135-4142, 1998
2. Amin RP, Vickers AE, Sistare F, Thompson KL, Roman RJ, Lawton M, Kramer J, HamadehHK, Collins J,GrissomS, Bennett L, TuckerCJ, Wild S, Kind C,Oreffo V, Davis JW2nd, Curtiss S, Naciff JM, CunninghamM, Tennant R, Stevens J, Car B, Bertram TA, Afshari CA: Identification of putative gene based markers of renal toxicity. Environ Health Perspect 112: 465-479, 2004
3. Vaidya VS, Ozer JS, Dieterle F, Collings FB, Ramirez V, Troth S, Muniappa N, Thudium D, Gerhold D, Holder DJ, Bobadilla NA, Marrer E, Perentes E, Cordier A, Vonderscher J, Maurer G, Goering PL, Sistare FD, Bonventre JV: Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nat Biotechnol 28: 478-485, 2010
4. Vaidya VS, Ramirez V, Ichimura T, Bobadilla NA, Bonventre JV: Urinary kidney injury molecule-1: A sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol 290: F517-F529, 2006
5. Vaidya VS, Waikar SS, Ferguson MA, Collings FB, Sunderland K, Gioules C, Bradwin G, Matsouaka R, Betensky RA, Curhan GC, Bonventre JV: Urinary biomarkers for sensitive and specific detectionof acute kidney injury in humans. Clin Transl Sci 1: 200-208, 2008
6. Ichimura T, Asseldonk EJ, Humphreys BD, Gunaratnam L, Duffield JS, Bonventre JV: Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J Clin Invest 118: 1657-1668, 2008
7. Humphreys BD, Xu F, Sabbisetti V, Grgic I, Naini SM,Wang N, Chen G, Xiao S, PatelD, HendersonJM, Ichimura T,Mou S, Soeung S,McMahon AP, Kuchroo VK, Bonventre JV: Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis. J Clin Invest 123: 4023-4035, 2013
8. Han WK, Alinani A, Wu CL, Michaelson D, Loda M, McGovern FJ, Thadhani R, Bonventre JV: Human kidney injury molecule-1 is a tissue and urinary tumormarker of renal cell carcinoma. J AmSoc Nephrol 16: 1126-1134, 2005
9. Kuehn EW, Park KM, Somlo S, Bonventre JV: Kidney injury molecule-1 expression in murine polycystic kidney disease. Am J Physiol Renal Physiol 283: F1326-F1336, 2002
10. Vaidya VS, Niewczas MA, Ficociello LH, Johnson AC, Collings FB, Warram JH, Krolewski AS, Bonventre JV: Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-b-Dglucosaminidase. Kidney Int 79: 464-470, 2011
11. Rennert PD: Novel roles for TIM-1 in immunity and infection. Immunol Lett 141: 28-35, 2011
12. Yeung M, McGrath M, Najafian N: The emerging role of the TIM molecules in transplantation. Am J Transplant 11: 2012-2019, 2011
13. Umetsu SE, Lee WL, McIntire JJ, Downey L, Sanjanwala B, Akbari O, Berry GJ, Nagumo H, Freeman GJ, Umetsu DT, DeKruyff RH: TIM-1 induces T cell activation and inhibits the development of peripheral tolerance. Nat Immunol 6: 447-454, 2005
14. Nakae S, Iikura M, Suto H, Akiba H, Umetsu DT, Dekruyff RH, Saito H, Galli SJ: TIM-1 and TIM-3 enhancement of Th2 cytokine production by mast cells. Blood 110: 2565-2568, 2007
15. Sizing ID, Bailly V, McCoon P, Chang W, Rao S, Pablo L, Rennard R, Walsh M, Li Z, Zafari M, Dobles M, Tarilonte L, Miklasz S, Majeau G, Godbout K, Scott ML, Rennert PD: Epitope-dependent effect of antimurine TIM-1 monoclonal antibodies on T cell activity and lung immune responses. J Immunol 178: 2249-2261, 2007
16. KhademiM, Illés Z, Gielen AW, MartaM, Takazawa N, Baecher-Allan C, Brundin L, Hannerz J, Martin C, Harris RA, Hafler DA, Kuchroo VK, Olsson T, Piehl F,WallströmE: T Cell Ig-andmucin-domain-containing molecule-3 (TIM-3) and TIM-1molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple sclerosis. J Immunol 172: 7169-7176, 2004
17. Xiao S,Najafian N, Reddy J, AlbinM, Zhu C, Jensen E, Imitola J, Korn T, Anderson AC, Zhang Z, Gutierrez C, Moll T, Sobel RA, Umetsu DT, Yagita H, Akiba H, Strom T, Sayegh MH, DeKruyff RH, Khoury SJ, Kuchroo VK: Differential engagement of Tim-1 during activation can positively or negatively costimulate T cell expansion and effector function. J ExpMed 204: 1691-1702, 2007
18. Ueno T, Habicht A, Clarkson MR, Albin MJ, Yamaura K, Boenisch O, Popoola J, Wang Y, Yagita H, Akiba H, Ansari MJ, Yang J, Turka LA, Rothstein DM, Padera RF, Najafian N, Sayegh MH: The emerging role of T cell Ig mucin 1 in alloimmune responses in an experimental mouse transplant model. J Clin Invest 118: 742-751, 2008
19. Nozaki Y, Nikolic-Paterson DJ, Snelgrove SL, Akiba H, Yagita H, Holdsworth SR, Kitching AR: Endogenous Tim-1 (Kim-1) promotes Tcell responses and cell-mediated injury in experimental crescentic glomerulonephritis. Kidney Int 81: 844-855, 2012
20. Nozaki Y, Nikolic-Paterson DJ, Yagita H, Akiba H, Holdsworth SR, Kitching AR: Tim-1 promotes cisplatin nephrotoxicity. Am J Physiol Renal Physiol 301: F1098-F1104, 2011
21. Lachmann A, Xu H, Krishnan J, Berger SI, Mazloom AR, Ma'ayan A: ChEA: Transcription factor regulation inferred from integrating genome-wide ChIP-X experiments. Bioinformatics 26: 2438-2444, 2010
22. Lachmann A, Ma'ayan A: KEA: Kinase enrichment analysis. Bioinformatics 25: 684-686, 2009
23. KimTM, Ramírez V, Barrera-Chimal J, BobadillaNA, Park PJ, Vaidya VS: Gene expression analysis reveals the cell cycle and kinetochore genes participating in ischemia reperfusion injury and early development in kidney. PLoS One 6: e25679, 2011
24. Krishnamoorthy A, Ajay AK, Hoffmann D, Kim TM, Ramirez V, Campanholle G, Bobadilla NA, Waikar SS, Vaidya VS: Fibrinogen b-derived Bb(15-42) peptide protects against kidney ischemia/reperfusion injury. Blood 118: 1934-1942, 2011
25. Basso K, Margolin AA, Stolovitzky G, Klein U, Dalla-Favera R, Califano A: Reverse engineering of regulatory networks in human B cells. Nat Genet 37: 382-390, 2005
26. Loots G, Ovcharenko I: ECRbase: Database of evolutionary conserved regions, promoters, and transcription factor binding sites in vertebrate genomes. Bioinformatics 23: 122-124, 2007
27. Berger SI, Posner JM,Ma'ayan A: Genes2Networks: Connecting lists of gene symbols using mammalian protein interactions databases. BMC Bioinformatics 8: 372, 2007
28. Jin Y, Ratnam K, Chuang PY, Fan Y, Zhong Y, Dai Y,Mazloom AR, Chen EY, D'Agati V, Xiong H, RossMJ, Chen N,Ma'ayan A, He JC: A systems approach identifiesHIPK2as a key regulatorof kidney fibrosis. NatMed 18: 580-588, 2012
29. Coresh J, Selvin E, Stevens LA,Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA 298: 2038-2047, 2007
30. Xue JL,Daniels F, Star RA,KimmelPL, Eggers PW,Molitoris BA,Himmelfarb J, Collins AJ: Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol 17: 1135-1142, 2006
31. Hsu CY, McCulloch CE, Fan D, Ordoñez JD, Chertow GM, Go AS: Community-based incidence of acute renal failure. Kidney Int 72: 208-212, 2007
32. Waikar SS, Curhan GC, Wald R, McCarthy EP, Chertow GM: Declining mortality in patients with acute renal failure, 1988 to 2002. J Am Soc Nephrol 17: 1143-1150, 2006
33. Bagshaw SM, George C, Bellomo R; ANZICS Database Management Committee: Changes in the incidence and outcome for early acute kidney injury in a cohort of Australian intensive care units. Crit Care 11: R68, 2007
34. Feliers D, Kasinath BS: Erk in kidney diseases. J Signal Transduct 2011: 768512, 2011
35. Park SK, Kang MJ, Kim W, Koh GY: Renal tubule regeneration after ischemic injury is coupled to the up-regulation and activation of cyclins and cyclin dependent kinases. Kidney Int 52: 706-714, 1997
36. Liu Q, Guntuku S, Cui XS, Matsuoka S, Cortez D, Tamai K, Luo G, Carattini-Rivera S, DeMayo F, Bradley A, Donehower LA, Elledge SJ: Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev 14: 1448-1459, 2000
37. Pabla N, Huang S,Mi QS, Daniel R, Dong Z: ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis. J Biol Chem283: 6572-6583, 2008
38. Chuang PY, He JC: JAK/STAT signaling in renal diseases. Kidney Int 78: 231-234, 2010
39. Freitas MC, Uchida Y, Zhao D, Ke B, Busuttil RW, Kupiec-Weglinski JW: Blockade of Janus kinase-2 signaling ameliorates mouse liver damage due to ischemia and reperfusion. Liver Transpl 16: 600-610, 2010
40. PangM, Ma L,Gong R, Tolbert E,Mao H, PonnusamyM, Chin YE, Yan H, Dworkin LD, Zhuang S: A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy. Kidney Int 78: 257-268, 2010
41. Liu N, Guo JK, Pang M, Tolbert E, Ponnusamy M, Gong R, Bayliss G, Dworkin LD, Yan H, Zhuang S: Genetic or pharmacologic blockade of EGFR inhibits renal fibrosis. J Am Soc Nephrol 23: 854-867, 2012
42. Furgason JM, Bahassi EM: Targeting DNA repair mechanisms in cancer. Pharmacol Ther 137: 298-308, 2013
43. Yang L, Besschetnova TY, Brooks CR, Shah JV, Bonventre JV: Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med 16: 535-543, 2010
44. Quinton LJ, Blahna MT, Jones MR, Allen E, Ferrari JD, Hilliard KL, Zhang X, Sabharwal V, Algül H, Akira S, Schmid RM, Pelton SI, Spira A, Mizgerd JP: Hepatocyte-specific mutation of both NF-kB RelA and STAT3 abrogates the acute phase response in mice. J Clin Invest 122: 1758-1763, 2012
45. Rong S, Park JK, Kirsch T, Yagita H, Akiba H, Boenisch O, Haller H, Najafian N, Habicht A: The TIM-1:TIM-4 pathway enhances renal ischemia-reperfusion injury. J Am Soc Nephrol 22: 484-495, 2011
46. Ichimura T, Brooks CR, Bonventre JV: Kim-1/Tim-1 and immune cells: Shifting sands. Kidney Int 81: 809-811, 2012
47. Lebel CP, Bondy SC: Sensitive and rapid quantitation of oxygen reactive species formation in rat synaptosomes. Neurochem Int 17: 435-440, 1990
48. Driver AS, Kodavanti PR, Mundy WR: Age-related changes in reactive oxygen species production in rat brain homogenates. Neurotoxicol Teratol 22: 175-181, 2000
49. Whiteman M, Dogra Y, Winyard PG, Armstrong JS: Detection and measurement of reactive oxygen intermediates in mitochondria and cells. Methods Mol Biol 476: 29-50, 2008
50. Ajay AK, Saikumar J, Bijol V, Vaidya VS: Heterozygosity for fibrinogen results in efficient resolution of kidney ischemia reperfusion injury. PLoS One 7: e45628, 2012